Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an ...

“The company is in a good place with its lead [cardiogenic shock treatment] program and ... began contemplating retiring from the day-to-day management of Windtree earlier this year after ...

sever sepsis, echocardiography, catheter-based treatments for acute cardiac emergencies, cardiac arrest and CPR, cardiogenic shock, heart failure and the role of surgical intervention.

Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...